The tumor-suppressive role of SHIP2 was found by Taylor et al. who observed that exogenous overexpression of SHIP2 negatively regulated AKT signalling pathway and repressed cell cycle progression in U87-MG glioblastoma cells to the same extent as PTEN18. The gene discussed is INPPL1; the disease is glioblastoma.